N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity

Virology

Volumn 215, Issue 2, 1996, Pages 124-133

  Sjölander, Sigrid ^a   Bolmstedt, Anders ^b   Åkerblom, Lennart ^c   Horal, Peter ^b   Olofsson, Sigvard ^b   Morein, Bror ^a,c   Sjölander, Anders ^c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; EPITOPE; GLYCAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD4; ASPARAGINE; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; GENE PRODUCTS, ENV; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROTEIN PRECURSORS; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030059955     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0015     Document Type: Article

References (63)

1. Åkerblom, L., Hinkula, J., Broliden, P. A., Mäkitalo, B., Fridberger, T., Rosen, J., Villacres-Eriksson, M., Morein, B., and Wahren, B. (1990). Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS 4, 953-960.
2. Akerblom, L., Nara, P., Dunlop, N., and Morein, B. (1991). Cross-neutralizing antibodies to HIV-1 in mice after immunization with gp160 iscoms. Dissection of the immune response. AIDS Res. Hum. Retroviruses 7, 621-627.
3. Atassi, M. Z., Yoshioka, M., and G S Bixler, J. (1989). T cells specific for α-β interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing. Proc. Natl. Acad. Sci. USA 86, 6729.
4. Back, N. K. T., Smit, L., de Jong, J. J., Keulen, W., Schutten, M., Goudsmit, J., and Tersmette, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
5. Benjouad, A., Gluckman, J.-C., Montagnier, L., and Bahraoui, E. (1993). Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160. J. Virol. 67, 1693-1697.
6. Benjouad, A., Gluckman, J. C., Rochat, H., Montagnier, L., and Bahroui, E. (1992). Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J. Virol. 66, 2473-2483.
7. Bolmstedt, A., Hemming, A., Flodby, P., Berntsson, P., Travis, B., Lin, J. P. C., Ledbetter, J., Tsu, T., Wigzell, H., Hu, S.-L., and Olofsson, S. (1991). Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins. J. Gen. Virol. 72, 1269-1277.
8. Bolmstedt, A., Olofsson, S., Sjögren-Jansson, E., Jeansson, S., Sjöblom, I., Åkerblom, L., Hansen, J.-E. S., and Hu, S.-L. (1992). Carbohydrate determinant NeuAc-Galβ(1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J. Gen. Virol. 73, 3099-3105.
9. Botarelli, P., Houlden, B. A., Haigwood, N. L., Servis, C., Montagna, D., and Abrignani, S. (1991). N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J. Immunol. 147, 3128-3132.
10. Dalgleish, A. G., Beverly, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
11. Doe, B., Steimer, K. S., and Walker, C. M. (1994). Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur. J. Immunol. 24, 2369-2376.
12. Doms, R. W., Lamb, R. A., Rose, J. K., and Helenius, A. (1993). Folding and assembly of viral membrane proteins. Virology 193, 545-562.
13. + T-cell recognition of influenza hemagglutinin by carbohydrate side chains located outside a T-cell determinant. Virology 192, 282-289.
14. Eriksson, K., Horal, P., Svennerholm, B., Jeansson, S., Vahlne, A., Holmgren, J., and Czerkinsky, C. (1993). Systemic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides. Vaccine 11, 859-865.
15. Fenouillet, E., Clerget-Raslain, B., Gluckman, J. C., Guétard, D., Montagnier, L., and Bahraoui, E. (1989). Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. J. Exp. Med. 169, 807-822.
16. Freed, E. O., and Martin, M. A. (1994). Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68, 2503-2512.
17. Fung, M. S. C., Sun, C. R. Y., Gordon, W. L., Liou, R.-S., Chang, T. W., Sun, W. N. C., Daar, E. S., and Ho, D. D. (1992). Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J. Virol. 66, 848-856.
18. Glimcher, L. H., Schoroer, J. A., Chan, C., and Shevach, E. M. (1983). Fine specificity of cloned insulin-specific T cell hybridomas: Evidence supporting a role for tertiary conformation. J. Immunol. 131, 2868.
19. Harding, C. V., Kihlberg, J., Elofsson, M., Magnusson, G., and Unanue, E. R. (1993). Glycopeptides bind MHC molecules and elicit specific T cell responses. J. Immunol. 151, 2419-2425.
20. Harding, C. V., Roof, R. W., Allen, P. M., and Unanue, E. R. (1991). Effects of pH and polysaccharide on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 88, 2740-2744.
21. Hemming, A., Bolmstedt, A., Flodby, P., Lundberg, L., Gidlund, M., Wigzell, H., and Olofsson, S. (1989a). Cystein 402 of HIV gp120 is essential for CD4-binding and restitance of gp120 to intracellular degradation. Arch. Virol. 109, 269-276.
22. Hemming, A., Bolmstedt, A., Jansson, B., S., H. J.-E., Hu, S.-L., and Olofsson, S. (1994). Identification of three N-linked glycans in the V4-V5 region, dispensable for CD4-binding and fusion activity of gp120. Arch. Virol. 134, 335-344.
23. Hemming, A., Lundberg, L., and Olofsson, S. (1989b). A strategy simplifying site-directed mutagenesis in the CD4-binding region of HIV gp120. Arch. Virol. 107, 301-305.
24. Ho, D. D., Fung, M. S. C., Cao, Y., Li, X. L., Sun, C., Chang, T. W., and Sun, N. C. (1988). Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science 239, 1021-1023.
25. Ho, D. D., Fung, M. S. C., Cao, Y., Sun, C., Chang, T. W., and Sun, N.-C. (1991a). Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by monoclonal antibody. Proc. Natl. Acad. Sci. USA 88, 8949-8952.
26. Ho, D. D., McKeating, J. A., Li, X. L., Moudgil, T., Daar, E. S., Sun, N. C., and Robinson, J. E. (1991b). Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65, 489-493.
27. Höglund, S., Daalsgard, K., Lövgren, K., Sundquist, B., Osterhaus, A., and Morein, B. (1989). Iscoms and immunostimulation with viral antigens. In "Subcell. Biochem." (R. J. Harris, Ed.), pp. 39-68. Plenum, New York.
28. Horal, P., Svennerholm, B., Jeansson, S., Rymo, L., Hall, W. W., and Vahlne, A. (1991). Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates. J. Virol. 65, 2718-2723.
29. Hu, S.-L., Kosowski, S. G., and Dalrymple, J. M. (1986). Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature 320, 537-540.
30. Ishioka, G. Y., Lamont, A. G., Thomson, D., Bulbow, N., Gaeta, F. C. A., Sette, A., and Grey, H. M. (1992). MHC interaction and T cell recognition of carbohydrates and glycopeptides. J. Immunol. 148, 2446-2451.
31. + T-cell clones. Virology 199, 422-430.
32. Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D., and Matthews, T. J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772.
33. Kang, C.-Y., Nara, P., Chamat, S., Caralli, V., Ryskamp, T., Haigwood, N., Newman, R., and Köhler, H. (1991). Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc. Natl. Acad. Sci. USA 88, 6171-6175.
34. Klaniecki, J., Dykers, T., Travis, B., Schmitt, R., Wain, M., Watson, A., Sridhar, P., McClure, J., Morein, B., Ulrich, J. T., Hu, S.-L., and Lewis, J. (1991). Cross-neutralizing antibodies in rabbits immunized with HIV gp160 purified from simian cells infected with a recombinant vaccinia virus. AIDS Res. Hum. Retroviruses 7, 791-798.
35. Klatzmann, D. E., Champagne, E., Chamaret, S., Gurest, J., Guetard, D., Hercend, T., Gluckman, J. C., and Montagnier, L. (1984). T-lymphocyte T4 molecule behave as receptor for human retrovirus LAV. Nature 312, 767-771.
36. Klenk, H. D. (1980). Processing of the hemagglutinin: Glycosylation and proteolytic cleavage. In "Structure and Variation in Influenza Virus" (W. G. Laver and G. Air, Eds.), pp. 213-222. Elsevier/North-Holland, Amsterdam.
37. Kukuruzinska, M. A., Bergh, M. L. E., and Jackson, B. J. (1987). Protein glycosylation in yeast. Annu. Rev. Biochem. 56, 915-944.
38. Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., and Capon, D. J. (1987). Delineation of region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50, 975-985.
39. Lechner, J. (1989). Structure and biosynthesis of procaryotic glycoproteins. Annu. Rev. Biochem. 58, 173-194.
40. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J N., and Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in chinese hamster ovary cells. J. Biol. Chem. 265, 10373-10382.
41. Lövgren, K., Lindmark, J., Pipkorn, R., and Morein, B. (1987). Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. J. Immunol. Methods 98, 137-143.
42. Matthews, T. J., Langlois, A. J., Robey, W. G., Chang, N. T., Gallo, R. C., Fischinger, P. J., and Bolognesi, D. P. (1986). Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83, 9709-9713.
43. Michaëlsson, E., Malmström, V., Reis, S., Engström, Å., Burkardt, H., and Holmdahl, R. (1994). T cell recognition of carbohydrates on type II collagen. J. Exp. Med. 180, 745-749.
44. Moore, J. P., Sattentau, Q. J., Wyatt, R., and Sodroski, J. (1994). Probing the structure of human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68, 469-484.
45. Mouritzen, S., Meldal, M., Ruud-Hansen, J., and Werdelin, O. (1991). T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by Cathepsin B, L and D. Scand. J. Immunol. 34, 421-431.
46. Muesing, M. A., Smith, D. H., Cabredilla, C. D., Benton, C. V., Lasky, L. A., and Capon, D. J. (1985). Nucleic acid structure an expression of the human AIDS/lymphadenopathy retrovirus. Nature 313, 450-458.
47. Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., and Sodroski, J (1990). Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64, 5701-5707.
48. Rademacher, T. W. (1992). Therapeutic challenges: Does glycobiology have a role. Trends Biotechnol. 10, 227-230.
49. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, A., Whitehorn, E. A., Baumeister, K., Ivanoff, L., Petteway, S. R., Pearson, M. L., Jr., Lautenberger, J. A., Papas, T. S., Ghrayeb, J., Chang, N. T., Gallo, R. C., and Wong-Staal, F. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
50. Ratner, L., Vander Heyden, N., and Dedera, D. (1991). Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity. Virology 181, 180-192.
51. Rouas, N., Christophe, S., Housseau, F., Bellet, D., Guillet, J. G., and Bidart, J. M. (1993). Influence of protein-quaternary structure on antigen processing. J. Immunol. 150, 782-792.
52. Rudensky, A. Y., Preston-Hurlburt, P., Hong, S. C., Barlow, A., and Janeway, C. A. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
53. Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F., and Poignard, P. (1993). Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67, 7383-7393.
54. Schwartz, R. H. (1985). T lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3, 237-261.
55. Sodora, D. L., Cohen, G. H., Muggeridge, M. I., and Eisenberg, R. J. (1991). Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein. J. Virol. 65, 4424-4431.
56. Steimer, K. S., Scandella, C. J., Skiles, P. V., and Haigwood, N. L. (1991). Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254, 105-108.
57. Tarentino, A. L., Gómez, C. M., and T H Plummer, J. (1985). Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry 24, 4665-4671.
58. Thali, M., Olshevsky, U., Furman, C., Gabuzda, D., Posner, M., and Sodrosky, J. (1991). Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65, 6188-6193.
59. + cytotoxic T cell recognition of endogenously processed antigen. J Immunol. 144, 2789-2794.
60. Towbin, H., Staehlin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
61. Unanue, E. R. (1992). Cellular studies on antigen presentation by class II MHC molecules. Curr. Opin. Immunol. 4, 63-69.
62. Vahlne, A., Horal, P., Eriksson, K., Jeansson, S., Rymo, L., Hedström, K. G., Czerkinsky, C., Holmgren, J. and Svennerholm, B. (1991). Immunization of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition. Proc. Natl. Acad. Sci. USA 88, 10744-10748.
63. Varki, A. (1993). Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3, 97-130.